COMBINATION CHEMOTHERAPY OF ARA-C-RESISTANT LEUKEMIA-P388 (P388 ARA-C) WITH INHIBITORS OF PURINE AND PYRIMIDINE BIOSYNTHESIS

被引：0
|
作者：
TRADER, MW [1 ]
SCHABEL, FM [1 ]
LASTER, WR [1 ]
BROCKMAN, RW [1 ]
机构：
[1] SOUTHERN RES INST,BIRMINGHAM,AL 35255
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1983年 / 24卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：265 / 265
页数：1
相关论文
共 50 条
  • [21] Lack of in vivo cross-resistance with 4′-thio-ara-C against drug-resistant murine P388 and L1210 leukemias
    William R. Waud
    Karen S. Gilbert
    John A. Secrist
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 399 - 403
  • [22] EXPRESSION OF PROTEIN-KINASE-C ISOZYMES IN MULTIDRUG-RESISTANT MURINE LEUKEMIA P388/ADR CELLS
    GUPTA, S
    KIM, C
    QIN, YF
    GOLLAPUDI, S
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (02) : 311 - 315
  • [23] CROSS-RESISTANCE TO PROTEIN-SYNTHESIS INHIBITORS OF AN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA
    CHITNIS, MP
    JOHNSON, RK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 189 - 189
  • [24] RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR ENHANCED CYTOTOXICITY OF ARA-C IN ARA-C-RESISTANT LEUKEMIC-CELLS FROM A PATIENT WITH BIPHENOTYPIC LEUKEMIA IN CELL KINETIC QUIESCENCE
    HIGASHIGAWA, M
    KOMADA, Y
    WASHIO, N
    KUWABARA, H
    HORI, H
    IDO, M
    SAKURAI, M
    LEUKEMIA RESEARCH, 1992, 16 (10) : 1049 - 1054
  • [25] COMPARISON OF UPTAKE OF MITOMYCIN-C AND KW-2149 BY MURINE P388 LEUKEMIA-CELLS SENSITIVE OR RESISTANT TO MITOMYCIN-C
    KOBAYASHI, E
    OKABE, M
    KONO, M
    ARAI, H
    KASAI, M
    GOMI, K
    LEE, JH
    INABA, M
    TSURUO, T
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 32 (01) : 20 - 24
  • [26] CHRONO-CHEMOTHERAPY OF L1210 LEUKEMIA WITH CYTOSINE-ARABINOSIDE (ARA-C) IN COMBINATION WITH CYCLOPHOSPHAMIDE (C) OR C AND VINCRISTINE (V)
    BURNS, ER
    SCHEVING, LE
    PAULY, JE
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 107 - 107
  • [27] UPTAKE AND EFFLUX OF C-14 PORFIROMYCIN IN AEROBIC AND HYPOXIC P388 MURINE LEUKEMIA-CELLS
    PAN, S
    IRACKI, T
    BACHUR, NR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 234 - 234
  • [28] EXPERIMENTAL APPROACH TO COMBAT DRUG-RESISTANCE BY THE USE OF EFFECTIVE CHEMOTHERAPY IN ADRIAMYCIN-RESISTANT SUBLINE OF P388 LEUKEMIA
    CHITNIS, MP
    INDIAN JOURNAL OF BIOCHEMISTRY & BIOPHYSICS, 1979, 16 (01): : 29 - 29
  • [29] Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
    Fu, CH
    Martin-Aragon, S
    Weinberg, KI
    Ardi, VC
    Danenberg, PV
    Avramis, VI
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (02) : 123 - 133
  • [30] Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein
    Cecilia H. Fu
    Sagrario Martin-Aragon
    Kenneth I. Weinberg
    Veronica C. Ardi
    Peter V. Danenberg
    Vassilios I. Avramis
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 123 - 133
12345